Icon
+91 94997 68112
Login Register

Ferriprox - (500 mg; Tablet, Oral)

Deferiprone Chiesi U.S.A
500 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Oral iron chelator for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
Yes
*** (****) ** *** ***** ** **** **** ** *** ********* **** ****** '*** (*** **, ****) *** *** ************ *********. ** ****** **** **** *** (****) ******* ** **** ****. *****, ********** ********* **** *** (****) *** ******** *******. ***** **** ***** * **** ** ** ****** '*** (*** **, ****) *** *** *********. ** ****** **** **** ***** ****** ** ** *** ****.
Ferriprox Patent 1
*** (****) *******
***** *******
*** *** ***********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** (****) *** \ *** **** **, **** ******* ******** ******** ** *** *, ****
***** ** \ ** *** *, **** ******* ******** ******** ** *** *, ****
  1. *** **, **** : *** (****) ******** ****** ***** *** **** ** **** ******* '*** (*** **, ****).
  2. *** **, **** : ****** *** ***** * **** ******* *** (****) ** ******** ***** ** ******* ******** ** ***** ******** ********.
  3. *** *, **** : ********** *** ********* **** *** (****) *** ****** '***(*** **, ****).
  4. *** *, **** : **** ******** *******
  5. *** **, **** : ***** ******** ****** *** ***** **'* **** ** ****** ** ****** '*** (*** **, ****).
  6. *** *, **** : ****** *** ***** * **** ******* ***** ** ****** '*** (*** **, ****).
  7. *** **, **** : ******’* ****** ********** ******** **** *** *** ******* *** ******** ********** *********** ** *********** ** * *********** ** ********* ******** **** **** ****** * ********** ***** ** ********** *** *******
  8. *** **, **** : ********** ********* **** *****

Ferriprox - (100MG/1ML, 80MG/1ML)

Deferiprone None
100MG/1ML, 80MG/1ML
Less Than $1000 mn
None None
None None
None None
FERRIPROX Oral Solution is an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with thalassemia syndromes, sickle cell disease or other anemias
Yes
Ferriprox Patent 1 Patent 2
*** *********
****** *********** *** *********** **** ********* *****

Ferriprox - (1000MG)

Deferiprone None
1000MG
Less Than $1000 mn
None None
None None
None None
FERRIPROX Tablets are an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes, sickle cell disease or other anemias.
Yes
Ferriprox Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
*** *********
******* ******* *********** ******* *** ******* ** ***** *** **** ******* ******* *********** ******* *** ******* ** ***** *** **** ******* ******* *********** ******* *** ******* ** ***** *** **** ******* ******* *********** ******* *** ******* ** ***** *** **** ******* ******* *********** ******* *** ******* ** ***** *** **** ******* ******* *********** ******* *** ******* ** ***** *** ****

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.